Sanofi Q4 Business Earnings Decline, Revenue Increases; 2025 Sales Growth Guidance Issued

MT Newswires Live

Jan 30, 2025

Sanofi (SNY) reported Q4 business earnings Thursday of 1.31 euros ($1.36) per share, down from 1.54 euros a year earlier.

Analysts' estimates were not readily available for comparison.

Revenue for the quarter ended Dec. 31 was 10.56 billion euros, up from 9.69 billion euros a year earlier.

Analysts surveyed by FactSet expected 10.83 billion euros.

For 2025, the French biopharmaceutical giant expects sales growth percentage in the mid to high single digits. Analysts polled by FactSet expect 46.33 billion euros.

Sanofi said it intends to launch a 5 billion euro share buyback program this year.

Shares of the company were up nearly 3% in Thursday's premarket activity.

Price: 53.75, Change: +1.60, Percent Change: +3.07

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2507645620"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2507645620\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2507645620?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-30 18:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2507645620","market":"sh","top_or_hot":-1,"title":"Sanofi Q4 Business Earnings Decline, Revenue Increases; 2025 Sales Growth Guidance Issued","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/GCVRZ\">Sanofi</a> (SNY) reported Q4 business earnings Thursday of 1.31 euros ($1.36) per share, down from 1.54 euros a year earlier.</p><p>Analysts' estimates were not readily available for comparison.</p><p>Revenue for the quarter ended Dec. 31 was 10.56 billion euros, up from 9.69 billion euros a year earlier.</p><p>Analysts surveyed by FactSet expected 10.83 billion euros.</p><p>For 2025, the French biopharmaceutical giant expects sales growth percentage in the mid to high single digits. Analysts polled by FactSet expect 46.33 billion euros.</p><p>Sanofi said it intends to launch a 5 billion euro share buyback program this year.</p><p>Shares of the company were up nearly 3% in Thursday's premarket activity.</p><p>Price: 53.75, Change: +1.60, Percent Change: +3.07</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sanofi Q4 Business Earnings Decline, Revenue Increases; 2025 Sales Growth Guidance Issued</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSanofi Q4 Business Earnings Decline, Revenue Increases; 2025 Sales Growth Guidance Issued\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-01-30 18:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/GCVRZ\">Sanofi</a> (SNY) reported Q4 business earnings Thursday of 1.31 euros ($1.36) per share, down from 1.54 euros a year earlier.</p><p>Analysts' estimates were not readily available for comparison.</p><p>Revenue for the quarter ended Dec. 31 was 10.56 billion euros, up from 9.69 billion euros a year earlier.</p><p>Analysts surveyed by FactSet expected 10.83 billion euros.</p><p>For 2025, the French biopharmaceutical giant expects sales growth percentage in the mid to high single digits. Analysts polled by FactSet expect 46.33 billion euros.</p><p>Sanofi said it intends to launch a 5 billion euro share buyback program this year.</p><p>Shares of the company were up nearly 3% in Thursday's premarket activity.</p><p>Price: 53.75, Change: +1.60, Percent Change: +3.07</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SNYNF","symbol_name":"Sanofi","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2507645620","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2507645620","pubTimestamp":1738232770,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Sanofi  reported Q4 business earnings Thursday of 1.31 euros  per share, down from 1.54 euros a year earlier.Analysts' estimates were not readily available for comparison.Revenue for the quarter ended Dec. 31 was 10.56 billion euros, up from 9.69 billion euros a year earlier.Analysts surveyed by FactSet expected 10.83 billion euros.For 2025, the French biopharmaceutical giant expects sales growth percentage in the mid to high single digits. Analysts polled by FactSet expect 46.33 billion euros.Sanofi said it intends to launch a 5 billion euro share buyback program this year.Shares of the company were up nearly 3% in Thursday's premarket activity.Price: 53.75, Change: +1.60, Percent Change: +3.07","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"SNYNF":"Sanofi","SNY":"赛诺菲安万特"},"translate_title":"赛诺菲Q4业务盈利下降，营收增长；发布2025年销售增长指引","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SNYNF":1,"SNY":0.9},"content_text":"Sanofi (SNY) reported Q4 business earnings Thursday of 1.31 euros ($1.36) per share, down from 1.54 euros a year earlier.Analysts' estimates were not readily available for comparison.Revenue for the quarter ended Dec. 31 was 10.56 billion euros, up from 9.69 billion euros a year earlier.Analysts surveyed by FactSet expected 10.83 billion euros.For 2025, the French biopharmaceutical giant expects sales growth percentage in the mid to high single digits. Analysts polled by FactSet expect 46.33 billion euros.Sanofi said it intends to launch a 5 billion euro share buyback program this year.Shares of the company were up nearly 3% in Thursday's premarket activity.Price: 53.75, Change: +1.60, Percent Change: +3.07","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}